Suchergebnisse
INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study
Shares of Insmed INSM gained nearly 6% on Monday after the company reported positive top-line results from the phase IIIb ENCORE study evaluating Arikayce for label expansion in mycobacterium avium
Iran War Chokes Helium Supply: Are US Semiconductor ETFs at Risk?
The intensifying war in the Middle East between Iran and the U.S.-Israel joint force has moved beyond a regional conflict, choking global energy supply lines. In a latest development, this conflict
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which evaluated its experimental Lyme disease vaccine, PF-07307405 (formerly
Chewy to Report Q4 Earnings: Essential Insights Ahead of the Report
Chewy, Inc. CHWY is likely to report top-line growth when it reports fourth-quarter fiscal 2025 results tomorrow. The Zacks Consensus Estimate for quarterly sales is currently pegged at $3.3
KB Home (KBH) Q1 Earnings Meet Estimates
KB Home (KBH) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.49 per share a year ago. These figures are adjusted for
KB Home Q1 Earnings Meet Estimates, Revenues Miss, Both Down Y/Y
KB Home KBH reported first-quarter fiscal 2026 results. The quarter’s earnings came in line with the Zacks Consensus Estimate, while total revenues missed the same. Both metrics decreased on a
AAR Q3 Earnings Surpass Estimates, Sales Increase Year Over Year
AAR Corp. AIR reported third-quarter fiscal 2026 adjusted earnings of $1.25 per share, which topped the Zacks Consensus Estimate of $1.21 by 3.3%. The bottom line also improved 26.3% from the
KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data
Shares of Karyopharm Therapeutics KPTI plunged 18.3% on Tuesday after the company reported mixed top-line results from a late-stage study evaluating a 60 mg dose of selinexor in combination with
NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data
Novo Nordisk NVO and its partner, The United Laboratories International Holdings Limited ("TUL"), jointly announced top-line data from a phase II study in China, evaluating UBT251, a novel triple
Jefferies (JEF) Matches Q1 Earnings Estimates
Jefferies (JEF) came out with quarterly earnings of $0.89 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.6 per share a year ago. These figures are adjusted
Enerpac (EPAC) Q2 Earnings Match Estimates
Enerpac (EPAC) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.39 per share a year ago. These figures are adjusted
JEF's Q1 Earnings Meet Estimates, Revenues Up on Solid IB Performance
Jefferies Financial Group’s JEF first-quarter fiscal 2026 (ended Feb. 28) adjusted earnings per share from continuing operations of 89 cents were in line with the Zacks Consensus Estimate. The
Flex Up 21% in the Past 6 Months: Can the Stock Climb Higher?
Flex Ltd.’s FLEX shares have appreciated 21.4% over the past six months, almost in line with the 21.2% growth recorded by the Zacks Electronics – Miscellaneous Products industry. The Zacks Computer
MRVL's Data Center Revenues Hit $6.1B: Can the Momentum Continue?
Marvell Technology MRVL posted strong results in fiscal 2026, with 74.4% of revenues coming from the data center business, which reached $6.1 billion. Given the contribution to MRVL’s top line and
McCormick Q1 Earnings on the Horizon: Is There a Beat in Store?
McCormick & Company, Incorporated MKC is likely to witness growth in both top and bottom lines when it reports first-quarter 2026 earnings on March 31, 2026. The Zacks Consensus Estimate for
Conagra Brands Q3 Earnings on Deck: What Should Investors Expect?
Conagra Brands, Inc. CAG is likely to witness a top and bottom-line decline when it reports third-quarter fiscal 2026 earnings on April 1. The Zacks Consensus Estimate for revenues is pegged at
NCLH Leans on Turnaround Strategy: Is Performance Set to Improve?
Norwegian Cruise Line Holdings Ltd. NCLH is entering a critical transition phase as it pivots toward a comprehensive turnaround strategy. The company has acknowledged that while its overarching
Apple's Expanding Enterprise Footprint to Boost Sales: What's Ahead?
Apple’s AAPL top-line is benefiting from an expanding enterprise footprint. In the first quarter of fiscal 2026, the company saw strong adoption with Snowflake deploying more than 9,000 Mac devices
PVH Q4 Earnings on the Horizon: Here's What Investors Should Know
PVH Corporation PVH is likely to post a year-over-year increase in its top and bottom lines when it reports fourth-quarter fiscal 2025 results on March 31, after market close. The Zacks Consensus



